SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001564590-19-039789
Filing Date
2019-11-04
Accepted
2019-11-04 16:10:24
Documents
13
Period of Report
2019-11-04
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K nbix-8k_20191104.htm   iXBRL 8-K 51441
2 EX-99.1 nbix-ex991_58.htm EX-99.1 249680
  Complete submission text file 0001564590-19-039789.txt   447045

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA nbix-20191104.xsd EX-101.SCH 5976
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE nbix-20191104_lab.xml EX-101.LAB 18732
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE nbix-20191104_pre.xml EX-101.PRE 11179
8 EXTRACTED XBRL INSTANCE DOCUMENT nbix-8k_20191104_htm.xml XML 3416
Mailing Address 12780 EL CAMINO REAL SAN DIEGO CA 92130
Business Address 12780 EL CAMINO REAL SAN DIEGO CA 92130 (858) 617-7600
NEUROCRINE BIOSCIENCES INC (Filer) CIK: 0000914475 (see all company filings)

IRS No.: 330525145 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-22705 | Film No.: 191189886
SIC: 2836 Biological Products, (No Diagnostic Substances)